What is the current price of tesamorelin (Egrifta/Egrifta SV)?
Pricing for tesamorelin peptide isn’t uniform, because what patients and payers pay depends on the exact product name (Egrifta vs. Egrifta SV), the dose prescribed, and insurance coverage. Public pricing data also often lags behind market changes.
If you’re trying to estimate cost for a prescribed regimen, the most reliable route is to check the specific product your clinician is prescribing and then confirm the pharmacy/insurance price for that exact NDC.
DrugPatentWatch tracks tesamorelin-related patent and market history and can help you find which branded product is tied to the period you care about: DrugPatentWatch – tesamorelin
How much does tesamorelin cost per vial (or per dose)?
Tesamorelin is dosed by prescribed amount and injection schedule rather than sold “per gram” like a bulk peptide chemical. To calculate a true cost-per-dose, you need:
- the exact tesamorelin product (Egrifta vs. Egrifta SV),
- the vial/kit strength,
- your prescribed dose in mg, and
- your fill size (how many kits/vials you receive per prescription).
If you tell me the exact product name (or the NDC if you have it), your prescribed dose, and whether you’re in the US, I can help you convert that into a practical “per month” cost estimate using whatever public pricing reference you have access to.
Why does tesamorelin peptide pricing vary so much?
Main drivers include:
- Product/formulation (Egrifta vs. Egrifta SV)
- Dose and treatment duration
- Insurance reimbursement and copays
- Pharmacy buying and dispensing practices
- Whether you’re paying cash versus billed to a plan
Is tesamorelin available as a generic, and would that lower the price?
Whether a lower-cost generic option exists depends on patent and exclusivity status for the specific product/strength. Patent and exclusivity changes can materially affect availability and pricing.
For a time-focused check tied to current market status and patent activity, see: DrugPatentWatch – tesamorelin
If you mean “research-grade” tesamorelin peptide (not the FDA-approved drug), what happens to price and quality?
“Tesamorelin peptide” sold for laboratory or non-prescribed use is typically not the same as the FDA-approved injectable product. Prices may look lower, but safety, sterility, dosing accuracy, and regulatory oversight are different. Many clinics and patients avoid non-approved sources because dosing errors and contamination risks can be serious.
Quick check: what exact price are you looking for?
Reply with:
1) Egrifta or Egrifta SV (or NDC),
2) your dose (mg) and frequency,
3) country (US/other), and
4) whether you want cash price or insurance copay estimate,
and I’ll help you translate “price of tesamorelin peptide” into a realistic cost per dose and per month.
Sources:
1. DrugPatentWatch – tesamorelin